Roxbury Financial »

Adma Biologics shares owned by Roxbury Financial

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Roxbury Financial from 13F filings

Historical chart of Roxbury Financial investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Roxbury Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Roxbury Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.5k 237 14.66
2025-06-30 $4.3k 237 18.21

More positions owned by Roxbury Financial

Microsoft Corp Stock (MSFT)
Fidelity Blue Chip Growth Etf Etf (FBCG)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Visa Inc Com Cl A Stock (V)
Fidelity Nasdaq Composite Index Etf Etf (ONEQ)
Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Amazon Stock (AMZN)
Fidelity Msci Consumer Staples Index Etf Etf (FSTA)
Jpmorgan Chase & Co Stock (JPM)
Wells Fargo Stock (WFC)
International Business Machs Stock (IBM)
Walmart Stock (WMT)
Mckesson Corp Stock (MCK)
Fidelity Msci Health Care Index Etf Etf (FHLC)

View all positions for Roxbury Financial

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Geode Capital Management
Nuveen
Westfield Capital Management Company
Dimensional Fund Advisors
American Century Companies
Thrivent Financial for Lutherans
Citadel Advisors
Capital Research Global Investors
Goldman Sachs Group
Franklin Resources

View all funds holding Adma Biologics